MOMETASONE FUROATE - Generic Drug Details
✉ Email this page to a colleague
What are the generic drug sources for mometasone furoate and what is the scope of patent protection?
Mometasone furoate
is the generic ingredient in eight branded drugs marketed by Organon, Merck Sharp Dohme, Anda Repository, Cosette, Fougera Pharms, Glenmark Generics, Taro, Intersect Ent Inc, Padagis Israel, Padagis Us, Torrent, Amneal Pharms, Apotex Inc, Perrigo Pharma Intl, and Glenmark Specialty, and is included in twenty-nine NDAs. There are twenty-five patents protecting this compound and two Paragraph IV challenges. Additional information is available in the individual branded drug profile pages.Mometasone furoate has forty-seven patent family members in twelve countries.
There are twenty-seven drug master file entries for mometasone furoate. Eighteen suppliers are listed for this compound.
Summary for MOMETASONE FUROATE
International Patents: | 47 |
US Patents: | 25 |
Tradenames: | 8 |
Applicants: | 15 |
NDAs: | 29 |
Drug Master File Entries: | 27 |
Finished Product Suppliers / Packagers: | 18 |
Raw Ingredient (Bulk) Api Vendors: | 70 |
Clinical Trials: | 133 |
Patent Applications: | 8,109 |
Formulation / Manufacturing: | see details |
Drug Prices: | Drug price trends for MOMETASONE FUROATE |
Drug Sales Revenues: | Drug sales revenues for MOMETASONE FUROATE |
Patent Litigation and PTAB cases: | See patent lawsuits and PTAB cases for MOMETASONE FUROATE |
What excipients (inactive ingredients) are in MOMETASONE FUROATE? | MOMETASONE FUROATE excipients list |
DailyMed Link: | MOMETASONE FUROATE at DailyMed |
Recent Clinical Trials for MOMETASONE FUROATE
Identify potential brand extensions & 505(b)(2) entrants
Sponsor | Phase |
---|---|
Pi Research Consultancy Center, Bangladesh | Early Phase 1 |
Hvidovre University Hospital | Phase 4 |
Xijing Hospital | N/A |
Pharmacology for MOMETASONE FUROATE
Drug Class | Corticosteroid |
Mechanism of Action | Corticosteroid Hormone Receptor Agonists Corticosteroid Hormone Receptor Agonists |
Medical Subject Heading (MeSH) Categories for MOMETASONE FUROATE
Paragraph IV (Patent) Challenges for MOMETASONE FUROATE
Tradename | Dosage | Ingredient | Strength | NDA | ANDAs Submitted | Submissiondate |
---|---|---|---|---|---|---|
NASONEX | Nasal Spray | mometasone furoate | 50 mcg/ Spray | 020762 | 1 | 2009-08-07 |
ELOCON | Topical Solution (Lotion) | mometasone furoate | 0.1% | 019796 | 1 | 2004-06-10 |
US Patents and Regulatory Information for MOMETASONE FUROATE
Expired US Patents for MOMETASONE FUROATE
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | Patent No. | Patent Expiration |
---|---|---|---|---|---|---|---|
Organon | ASMANEX HFA | mometasone furoate | AEROSOL, METERED;INHALATION | 205641-001 | Apr 25, 2014 | See Plans and Pricing | See Plans and Pricing |
Organon | ASMANEX TWISTHALER | mometasone furoate | POWDER;INHALATION | 021067-002 | Feb 1, 2008 | See Plans and Pricing | See Plans and Pricing |
Organon | ASMANEX TWISTHALER | mometasone furoate | POWDER;INHALATION | 021067-002 | Feb 1, 2008 | See Plans and Pricing | See Plans and Pricing |
Organon | ASMANEX TWISTHALER | mometasone furoate | POWDER;INHALATION | 021067-002 | Feb 1, 2008 | See Plans and Pricing | See Plans and Pricing |
Organon | ASMANEX TWISTHALER | mometasone furoate | POWDER;INHALATION | 021067-002 | Feb 1, 2008 | See Plans and Pricing | See Plans and Pricing |
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >Patent No. | >Patent Expiration |
International Patents for MOMETASONE FUROATE
Country | Patent Number | Title | Estimated Expiration |
---|---|---|---|
China | 106039547 | 可展开装置及其使用方法 (Expandable devices and methods therefor) | See Plans and Pricing |
Japan | 6757761 | See Plans and Pricing | |
Japan | 2016512129 | 副鼻腔状態を処置するためのシステム、デバイスおよび方法 | See Plans and Pricing |
Canada | 2761769 | DISPOSITIFS EXPANSIBLES ET PROCEDES POUR LES UTILISER (EXPANDABLE DEVICES AND METHODS THEREFOR) | See Plans and Pricing |
World Intellectual Property Organization (WIPO) | 2010132648 | See Plans and Pricing | |
>Country | >Patent Number | >Title | >Estimated Expiration |
Supplementary Protection Certificates for MOMETASONE FUROATE
Patent Number | Supplementary Protection Certificate | SPC Country | SPC Expiration | SPC Description |
---|---|---|---|---|
0548114 | SPC/GB97/064 | United Kingdom | See Plans and Pricing | PRODUCT NAME: MOMETASONE FUROATE MONOHYDRATE; REGISTERED: FR AMM 343012.6 19970219; UK 00201/0216 19970410 |
0112669 | 96C0002 | Belgium | See Plans and Pricing | PRODUCT NAME: MOMETASONE FUROATE; NAT. REGISTRATION NO/DATE: NL 19601 19950919; FIRST REGISTRATION: GR - 10681/89 19900622 |
>Patent Number | >Supplementary Protection Certificate | >SPC Country | >SPC Expiration | >SPC Description |
Make Better Decisions: Try a trial or see plans & pricing
Serving leading biopharmaceutical companies globally:






Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.